ISRG - Reasons to Retain Intuitive Surgical in Your Portfolio | Benzinga
Intuitive Surgical, Inc. (NASDAQ: ISRG) is well-poised for growth in the coming quarters, courtesy of its strength in robotics. The optimism, led by solid results in the last few quarters and its progress on the Artificial Intelligence front, is expected to contribute further. However, procedure adoption risks and stiff competition persist.
Shares of this Zacks Rank #3 (Hold) company have risen 23.8% year to date compared with the industry's 6.6% growth. The S&P 500 Index has gained 12.4% during the same time frame.
Intuitive Surgical, the pioneer of robotic-assisted surgery and a renowned provider of minimally invasive care, has a market capitalization of $148.13 billion. It projects 16.1% growth over the next five years.
The company's earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, delivering an average surprise of 6.78%.
Image Source: Zacks Investment Research
Let's delve deeper.
Strength in Robotics: We are upbeat about Intuitive Surgical's robot-based da Vinci surgical system that enables minimally invasive surgery and reduces the trauma associated with open surgery. The da Vinci System is powered by robotic technology that has provided the company with solid exposure to medical mechatronics, robotics and AI for the healthcare space. The company has gained FDA clearance for its da Vinci 5 fifth-generation multiport robotic system, earlier this month. The system is believed to be the smoothest and most accurate device in ISRG's portfolio.
On its first-quarter 2024 earnings call, the company stated that its installed base of the da Vinci system grew approximately ...